16 terminated. 16 Phase 2, 7 Phase 3, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Terminated 16 |
| Phase 3 | 7 | Terminated 7 |
| Phase 1 | 4 | Terminated 4 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Naltrexone In Pediatric Eating Disorders Naltrexone Hydrochloride, Control - Anorexia Nervosa/Bulimia, Anorexia in Adolescence | Phase 2 / Phase 3 | Terminated | Rosemary Claire Roden | 9 | 2022-04-22 | 2025-08-19 |
| Ivermectin in Adults With Severe COVID-19. Ivermectin, Placebo - Covid19, Severe Acute Respiratory Syndrome | Phase 2 | Terminated | CES University | 75 | 2020-12-10 | 2022-01-04 |
| Reparixin in COVID-19 Pneumonia - Efficacy and Safety Reparixin, Standard of care - Severe Pneumonia | Phase 2 / Phase 3 | Terminated | Dompé Farmaceutici S.p.A | 56 | 2020-05-05 | 2024-01-08 |
| Nitrite Infusion in Islet Cell Transplantation Control, Pre-Isolation Infusion, Post-Isolation Infusion - Diabetes | Phase 2 | Terminated | University of Alabama at Birmingham | 4 | 2017-05-07 | 2020-10-29 |
| Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea Ketamine, Control - Sleep Apnea, Obstructive Sleep Apnea | Phase 2 / Phase 3 | Terminated | University of Alabama at Birmingham | 9 | 2016-06-02 | 2019-12-19 |
| Fenofibrate and Propranolol in Burn Patients Fenofibrate, Placebo, Propranolol - Burn | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 18 | 2015-11-01 | 2019-11-29 |
| Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation Reparixin, Control - Ischemia-reperfusion Injury in Liver Transplant, Early Allograft Dysfunction | Phase 2 | Terminated | Dompé Farmaceutici S.p.A | 40 | 2015-03-10 | 2025-01-07 |
| CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle 200ppm CO for one hour, Control - Cardiac Disease, Mitochondrial Biogenesis | Phase 1 / Phase 2 | Terminated | John J Freiberger | 1 | 2014-02-01 | 2016-05-19 |
| Propranolol in Severely Burned Children Propranolol, Placebo - Burn | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 63 | 2013-12-01 | 2019-09-24 |
| Protective Effects of Propranolol in Adults Propranolol, Placebo - Burn | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 47 | 2013-07-01 | 2019-11-29 |
| Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort Probiotics, Control - Abdominal Discomfort | Phase 2 | Terminated | Probi AB | 5 | 2013-04-01 | 2016-09-22 |
| Techniques to Enhance Patient Comfort in Sedation-risk Free Colonoscopy Warm water, Control - Screening of Colonic Polyps | Phase 1 / Phase 2 | Terminated | VA Greater Los Angeles Healthcare System | 85 | 2007-12-01 | 2015-12-15 |
| Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis PH-10 (rose bengal disodium 0.001%), Control - Plaque Psoriasis | Phase 2 | Terminated | Provectus Pharmaceuticals | 6 | 2007-11-01 | 2021-12-16 |
| The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema Pegaptanib Sodium, Control - Cystoid Macular Edema | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 1 | 2006-07-01 | 2008-05-12 |
| Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics Pegaptanib sodium, Control - Cystoid Macular Edema | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 4 | 2006-06-01 | 2008-05-12 |
| Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 1126 | 2004-01-01 | 2019-11-29 |
Burns (4) · COVID-19 (2) · Macular Edema (2) · Reperfusion Injury (2) · Anorexia Nervosa (1) · Bulimia (1) · Bulimia Nervosa (1) · Diabetes Mellitus (1) · Feeding and Eating Disorders (1) · Heart Diseases (1) · Impulsive Behavior (1) · Insulin Resistance (1) · Motor Activity (1) · Pneumonia (1) · Pneumonia, Viral (1)
The University of Texas Medical Branch, Galveston (4) · Dompé Farmaceutici S.p.A (2) · Johns Hopkins University (2) · University of Alabama at Birmingham (2) · CES University (1) · John J Freiberger (1) · Probi AB (1) · Provectus Pharmaceuticals (1) · Rosemary Claire Roden (1) · VA Greater Los Angeles Healthcare System (1)
United States (12) · Belarus (1) · Brazil (1) · Canada (1) · Colombia (1) · Germany (1) · Italy (1) · Russia (1)
David N Herndon, MD (4) · Alberto Zangrillo, MD PhD (1) · Amir Larian, MD (1) · Blair Smith, MD (1) · Diana V. Do, MD (1) · Felix W. Leung, MD (1) · Francisco L Ochoa-Jaramillo, MD; MSc (1) · Lorenzo Piemonti, MD PhD (1) · Oliver D. Schein, MD, MPH, MBA (1) · Peter A Nagi, MD (1) · Rosemary C Roden, MD (1) · Sergey Vladimirovich Zhuravel, MD (1)
PMID 19734776, PMID 20881067, PMID 22463890, PMID 22606232, PMID 22895351, PMID 23150682, PMID 23303450, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 27171844, PMID 27433905, PMID 28240622, PMID 35618953, PMID 36167287
P50GM060338 (1)